223PThe impact of neoadjuvant dual HER2 targeting with pertuzumab and trastuzumab on pathological complete response (pCR) rates: Kent Oncology Centre (KOC) experience.
Saved in:
| Title: | 223PThe impact of neoadjuvant dual HER2 targeting with pertuzumab and trastuzumab on pathological complete response (pCR) rates: Kent Oncology Centre (KOC) experience. |
|---|---|
| Authors: | Forner, S1 (AUTHOR), Sim, V R1 (AUTHOR), Glendenning, J L1 (AUTHOR), Burcombe, R1 (AUTHOR) |
| Source: | Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. 1 Chart. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
